
Methods and Applications of Statistics in Clinical Trials, Volume 2
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
Reviews / Votes
"This book provides a good overview on most relevant topics for clinical trials." (Biometrical Journal, 1 October 2015)More details
Other editions
Additional editions



Person
Content
Contributors
Per Kragh Andersen, University of Copenhagen, Copenhagen, Denmark, pka@biostat.ku.dk
Garnet L. Anderson, Fred Hutchinson Cancer Research Center, Seattle, WA, garnet@whi.org
Chul Ahn, University of Texas Southwestern Medical Center, Dallas, TX, chul.ahn@utsouthwestern.edu
Edgar Brunner, Professor Emeritus of Biostatistics, University Medical Center, Göttingen, Germany, Edgar.Brunner@ams.med.uni-goettingen.de
Jürgen B. Bulitta, State University of New York at Buffalo, Buffalo, NY, Jurgen.Bulitta@monash.edu
Jianwen Cai, University of North Carolina, Chapel Hill, NC, cai@bios.unc.edu
Patrizio Capasso, University of Kentucky, Lexington, KY, patriziocapasso@aol.com
Robert C. Capen, Merck Research Laboratories West Point, PA
Jhelum Chakravorty, McGill University, Montreal, QC, Canada, jhelum.chakravorty@mail.mcgill.ca
Chi Wan Chen, Pfizer Inc., New York, NY
David H. Christiansen, Christiansen Consulting, Boise, ID
Shein-Chung Chow, Duke University Durham, NC, sheinchung.chow@duke.edu
Joseph F. Collins
Jason T. Connor, Berry Consultants, Orlando, FL, jason@berryconsultants.com
Richard J. Cook, University of Waterloo, Waterloo, ON, Canada, rjcook@uwaterloo.ca
Xiangqin Cui, University of Alabama at Birmingham, Birmingham, AL. xcui@uab.edu
C. B. Dean, Western University, Western Science Centre, London, ON, Canada, dean@stats.uwo.ca
Yu Deng, University of North Carolina, Chapel Hill, NC, ydeng@bios.unc.edu
Diane L. Fairclough, University of Colorado Health Sciences, Center Denver, CO, dianefairclough@earthlink.net
John R. Feussner, Medical University of South Carolina, Charleston, SC
Boris Freidlin, National Cancer Institute, Bethesda, MD, freidlinb@ctep.nci.nih.gov
Patricia A. Granz, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, pganz@ucla.edu
Courtney Gray-McGuire, Case Western Reserve University, Cleveland, OH, courtney.gray-mcguire@case.edu
Birgit Grund, University of Minnesota, Minneapolis, MN, birgit@umn.edu
Kilem L. Gwet, Advanced Analytics, LLC, Gaithersburg, MD, gwet62@gmail.com
H. R. Hapsara, World Health Organization, Geneva, Switzerland, hapsarah@who.org
William R. Hendee, Medical College of Wisconsin, Milwaukee, WI, whendee@mcw.edu
William G. Henderson
Tim Hesterberg, Insightful Corporation, Seattle, WA
Nicholas H. G. Holford, University of Auckland, Auckland, New Zealand, n.Holford@auckland.ac.nz
Norbert Holländer, University Hospital of Freiburg, Freiburg, Germany, norbert.hollaender@novartis.com
David W. Hosmer, University of Massachusetts, Amherst, MA, hosmer@schoolph.umass.edu
Alan D. Hutson, University at Buffalo, Buffalo, NY, ahutson@buffalo.edu
Peter B. Imrey, Cleveland Clinic, Cleveland, OH, imreyp@ccf.org
Elizabeth Juarez-Colunga, University of Colorado Denver, Aurora, CO, elizabeth.juarez-colunga@ucdenver.edu
Seung-Ho Kang, Ewha Woman’s University, Seoul, South Korea
Jörg Kaufmann, AG Schering SBU Diagnostics & Radiopharmaceuticals, Berlin, Germany
Niels Keiding, University of Copenhagen, Copenhagen, Denmark, nike@sund.ku.dk
Célestin C. Kokonendji, University of Franche-Comté, Besançon, France, celestin.kokonendji@univ-fcomte.fr
Helena Chmura Kraemer, Stanford University, Palo Alto, CA, hckhome@pacbell.net
John M. Lachin, George Washington University, Washington, DC, jml@bsc.gwu.edu
Philip W. Lavori, Stanford University School of Medicine, Standford, CA, lavori@stanford.edu
Morven Leese, Institute of Psychiatry—Health Services and Population Research Department, London, UK
Stanley Lemeshow, Ohio State University, Columbus, OH, lemeshow.1@osu.edu
Jason J. Z. Liao, Merck Research Laboratories West Point, PA, Jason.Liao@tevausa.com
Tsae-Yun Daphne Lin, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD, daphne.lin@fda.hhs.gov
Qing Lu, Michigan State University, East Lansing, MI, qlu@msu.edu
Aditya Mahajan, McGill University, Montreal, QC, Canada, aditya.mahajan@mcgill.ca
Michael A. McIsaac, University of Waterloo, Waterloo, ON, Canada, mamcisaa@uwaterloo.ca
David Moher, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada and Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada, dmoher@ohri.ca
Grier P. Page, RTI International, Research Triangle Park, NC, gpage@rti.org
Peter Peduzzi, Yale School of Public Health, New Haven, CT, peter.peduzzi@yale.edu
Ross L. Prentice, Fred Hutchinson Cancer Research Center, Seattle, WA, rprentic@fhcrc.org
Philip C. Prorok, National Institutes of Health, Bethesda, MD, Philip.Prorok@nih.hhs.gov
Michael A. Proschan, National Institute of Allergy and Infectious Diseases, Bethesda, MD, ProschaM@mail.nih.gov
Frank Rockhold, GlaxoSmithKline R&D, King of Prussia, PA, frank.w.rockhold@gsk.com
Hannah R. Rothstein, City University of New York, NY, Hannah.Rothstein@baruch.cuny.edu
W. Janusz Rzeszotarski, U.S. Food and Drug Administration, Rockville, MD
Mike R. Sather, Department of Veterans Affairs, Albuquerque, NM, mike.sather@va.gov
Tony Segreti, Research Triangle Institute, Research Triangle, NC
Larissa Shamseer, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada and Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada, lshamseer@ohri.ca
Joanna H. Shih, National Cancer Institute, Bethesda, MD
Richard M. Simon, National Cancer Institute, Bethesda, MD, rsimon@mail.nih.gov
Yeunjoo Song, Case Western Reserve University, Cleveland, OH
Chris Stevenson, Monash University, Victoria, Australia, Christopher.Stevenson@monash.edu
Samy Suissa, McGill University, Montreal, QC, Canada, samy.suissa@clinepi.mcgill.ca
Ming T. Tan, Georgetown University, Washington, DC, mtt34@georgetown.edu
Duncan C. Thomas University of Southern California, Los Angeles, CA, dthomas@usc.edu
Susan Todd, University of Reading Reading, Berkshire, UK, s.c.todd@reading.ac.uk
Lucy Turner, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada, lturner@ohri.ca
Albert Vexler, University at Buffalo, Buffalo, NY, avexler@buffalo.edu
Hansheng Wang, Peking University Beijing, P. R. China, hansheng@gsm.pku.edu.cn
Xikui Wang, University of Manitoba, Winnipeg, MN, Canada, xikui.wang@umanitoba.ca
C. S. Wayne Weng, Chung Yuan Christian University, Chungli, Taiwan
Andreas Wienke, University Halle-Wittenberg, Halle, Germany, andreas.wienke@uk-halle.de
Anthony B. Wolbarst, University of Kentucky, Lexington, KY,...
System requirements
File format: ePUB
Copy protection: Adobe-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Install the free reader Adobe Digital Editions prior to download (see eBook Help).
- Tablet/smartphone (Android; iOS): Install the free app Adobe Digital Editions or the app PocketBook before downloading (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (not Kindle).
The file format ePub works well for novels and non-fiction books – i.e., „flowing” text without complex layout. On an e-reader or smartphone, line and page breaks automatically adjust to fit the small displays.
This eBook uses Adobe-DRM, a „hard” copy protection. If the necessary requirements are not met, unfortunately you will not be able to open the eBook. You will therefore need to prepare your reading hardware before downloading.
Please note: We strongly recommend that you authorise using your personal Adobe ID after installation of any reading software.
For more information, see our ebook Help page.